EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:177871 - brequinar sodium
| Formula | C23H14F2NO2.Na |
| Net Charge | 0 |
| Average Mass | 397.356 |
| Monoisotopic Mass | 397.08903 |
| SMILES | Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)[O-].[Na+] |
| InChI | InChI=1S/C23H15F2NO2.Na/c1-13-21(23(27)28)18-12-16(24)10-11-20(18)26-22(13)15-8-6-14(7-9-15)17-4-2-3-5-19(17)25;/h2-12H,1H3,(H,27,28);/q;+1/p-1 |
| InChIKey | PZOHOALJQOFNTB-UHFFFAOYSA-M |
| Roles Classification |
|---|
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. antimetabolite A substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization. anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. pyrimidine synthesis inhibitor A pathway inhibitor that inhibits the synthesis of pyrimidine. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor An EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitor that interferes with the action of dihydroorotate dehydrogenase (quinone), EC 1.3.5.2. |
| Applications: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| brequinar sodium (CHEBI:177871) has part brequinar(1−) (CHEBI:177870) |
| brequinar sodium (CHEBI:177871) has role anticoronaviral agent (CHEBI:149553) |
| brequinar sodium (CHEBI:177871) has role antimetabolite (CHEBI:35221) |
| brequinar sodium (CHEBI:177871) has role antineoplastic agent (CHEBI:35610) |
| brequinar sodium (CHEBI:177871) has role antiviral agent (CHEBI:22587) |
| brequinar sodium (CHEBI:177871) has role EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor (CHEBI:77103) |
| brequinar sodium (CHEBI:177871) has role immunosuppressive agent (CHEBI:35705) |
| brequinar sodium (CHEBI:177871) has role pyrimidine synthesis inhibitor (CHEBI:68543) |
| brequinar sodium (CHEBI:177871) is a organic sodium salt (CHEBI:38700) |
| IUPAC Name |
|---|
| sodium 6-fluoro-2-(2'-fluoro[biphenyl]-4-yl)-3-methylquinoline-4-carboxylate |
| Synonyms | Source |
|---|---|
| 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinoline-carboxylic acid sodium salt | ChEBI |
| brequinar sodium salt | ChemIDplus |
| DUP 785 | ChemIDplus |
| DUP-785 | ChEBI |
| NSC 368390 | ChemIDplus |
| NSC-368390 | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 51421 | ChemSpider |
| D03154 | KEGG DRUG |
| DBSALT002498 | DrugBank |
| Registry Numbers | Sources |
|---|---|
| CAS:96201-88-6 | ChemIDplus |
| Citations |
|---|